Inventor · disambiguated record
Xiang Y. Yu
Also filed as: YU XIANG · YU XIANG Y · YU XIANG YANG
17 granted patents·15 pending applications·86 citations·filing 1999–2023
92Inventor score
Files withEPIX PHARM INC6ACURX PHARMACEUTICALS LLC4ACTIVBIOTICS INC3ACTIVBIOTICS PHARMA LLC3CUBIST PHARM INC2
Top patents by PatentIndex Score
32 records- 0188US8987271B22,2′-biphenazine compounds and methods useful for treating diseaseCARDONE MICHAEL H·Filed 2011·Granted Mar 24, 2015·12 cites·6 claims
- 0288US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 0386US7968538B2Substituted arylamine compounds and methods of treatmentGALENEA CORP·Filed 2006·Granted Jun 28, 2011·17 cites·60 claims
- 0483US7547692B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2006·Granted Jun 16, 2009·10 cites·18 claims
- 0579US9351971B2Substituted 2,2′-biphenazines for treating diseasesEUTROPICS PHARMACEUTICALS INC·Filed 2015·Granted May 31, 2016·3 cites·20 claims
- 0678US7271165B2Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2004·Granted Sep 18, 2007·12 cites·6 claims
- 0777US7855193B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2006·Granted Dec 21, 2010·3 cites·11 claims
- 0876US7790707B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Sep 7, 2010·2 cites·11 claims
- 0974US7488726B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2006·Granted Feb 10, 2009·2 cites·17 claims
- 1071US8080542B2S1P receptor modulating compounds and use thereofNEIRA SUSANA C·Filed 2008·Granted Dec 20, 2011·2 cites·8 claims
- 1171US7408025B2Lipopeptides as antibacterial agentsCUBIST PHARM INC·Filed 2000·Granted Aug 5, 2008·5 cites·30 claims
- 1270US7494991B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2007·Granted Feb 24, 2009·1 cites·21 claims
- 1370US2009011977A1Novel Lipopeptides as Antibacterial AgentsHILL JASON·Filed 2008·Application pending·0 cites
- 1469US10723741B1DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·11 claims
- 1569US2022112195A1DNA Polymerase IIIC Inhibitors and Use ThereofACURX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1668US11001592B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted May 11, 2021·0 cites·17 claims
- 1767US10836772B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted Nov 17, 2020·0 cites·6 claims
- 1862US2025333406A1Sulfonyl cyclic derivatives, and compositions and methods thereofLYSOWAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1959US2008287347A1Novel Lipopeptides as Antibacterial AgentsHILL JASON·Filed 2008·Application pending·0 cites
- 2058US2025009846A1Recombinant protein of nerve growth factor mutant and use thereofSHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE·Filed 2022·Application pending·0 cites
- 2158US2025221989A1Pharmaceutical composition, use thereof, and method for treating cancerGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 2253US2010273765A1Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2007·Application pending·0 cites
- 2351US7220738B2Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2004·Granted May 22, 2007·0 cites·12 claims
- 2451US2025171461A1Stimulator of interferon genes (sting) modulators, and compositions and methods thereofGEODE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2551US2016022625A1Tashinones and their derivatives: novel excellent drugs for alzheimer diseaseZHENG JIE·Filed 2014·Application pending·0 cites
- 2649US2024182465A1Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 2746US6153645AHeterocycles as antimicrobial agentsCUBIST PHARM INC·Filed 1999·Granted Nov 28, 2000·3 cites·27 claims
- 2846US2024166617A1Phosphoinositide 3 kinase beta inhibitors and compositions and methods thereofGEODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2944US2010317649A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2010·Application pending·0 cites
- 3044US2011212940A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2011·Application pending·0 cites
- 3143US2011059945A1S1P Receptor Modulating Compounds and Use ThereofEPIX PHARM INC·Filed 2010·Application pending·0 cites
- 3241US2012088749A1S1P Receptor Modulating Compounds and Use ThereofNEIRA SUSANA C·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiang Y. Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →